Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors
Julie L. Lucas, Robert P. Numerof(Bayer (United States)), Eric J. Haas-Stapleton(Bayer (United States)), Thomas M. Zollner(Bayer (Germany)), Parham Mirshahpanah(Bayer (United States)), Khusru Asadullah(University of Potsdam)
Cited by 90
Related Papers
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
|BMC Cancer|2012|561
Psoriasis: a possible risk factor for development of coronary artery calcification
|British Journal of Dermatology|2006|376
Proteasome inhibition: a new anti-inflammatory strategy
|Journal of Molecular Medicine|2003|221
Endothelial P-Selectin as a Target of Heparin Action in Experimental Melanoma Lung Metastasis
|Cancer Research|2004|195
Menstruation pulls the trigger for inflammation and pain in endometriosis
|Trends in Pharmacological Sciences|2015|145